OptiBiotixs LPLDL cholesterolreducing strain to be used in vascular health product

OptiBiotix’s LPLDL cholesterol-reducing strain to be used in vascular health product

03:33 EDT 1 Jul 2019 | Proactive Investors

Opti’s LPLDL strain is to be mixed with Kappa Bioscience’s K2VITAL vitamin to create a new vascular health product

More From BioPortfolio on "OptiBiotix’s LPLDL cholesterol-reducing strain to be used in vascular health product"